Results of log-rank test demonstrated that the high expressions of AHNAK, HSPG2, and PCSK9 were associated with the low OS, while the high expression of POU5F1 and FASTKD3 was associated with the high OS of BLCA patients (Figure 3). This evidence concerns the gene HSPG2 and bladder transitional cell carcinoma.